Evidence map›Paper›PMID 35671566›Full record

ReviewAnnual review of virology2022

Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses.

Mette M Rosenkilde, Naotaka Tsutsumi, Julius M Knerr, Dagmar F Kildedal, K Christopher Garcia

Open access · hybridAbstract readReview
In one paragraph

Review in Annual review of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Structural insights into KSHV-GPCR constitutive activation and CXCL1 chemokine recognition.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Cryo-EM structure of the human chemerin receptor 1-Gi protein complex bound to the C-terminal nonapeptide of chemerin.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Mette M RosenkildeDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; email: rosenkilde@sund.ku.dk.
Naotaka TsutsumiGraduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Julius M KnerrDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; email: rosenkilde@sund.ku.dk.
Dagmar F KildedalSynklino Aps, Charlottenlund, Denmark.
K Christopher GarciaDepartments of Molecular and Cellular Physiology, and Structural Biology, and Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California, USA; email: kcgarcia@stanford.edu.
University of Copenhagen · DKOkayama University · JPStanford University · US

Funding

Viral GPCR recognition of chemokines and engineered ligandsR01AI125320 · NIAID · STANFORD UNIVERSITY · PI GARCIA, KENAN CHRISTOPHER · 2016 to 2020
$2.0M
NIAID NIH HHS R01 AI125320
6 · The paper itself

Abstract

Herpesviruses are ancient large DNA viruses that have exploited gene capture as part of their strategy to escape immune surveillance, promote virus spreading, or reprogram host cells to benefit their survival. Most acquired genes are transmembrane proteins and cytokines, such as viral G protein-coupled receptors (vGPCRs), chemokines, and chemokine-binding proteins. This review focuses on the vGPCRs encoded by the human β- and γ-herpesviruses. These include receptors from human cytomegalovirus, which encodes four vGPCRs: US27, US28, UL33, and UL78; human herpesvirus 6 and 7 with two receptors: U12 and U51; Epstein-Barr virus with one: BILF1; and Kaposi's sarcoma-associated herpesvirus with one: open reading frame 74, ORF74. We discuss ligand binding, signaling, and structures of the vGPCRs in light of robust differences from endogenous receptors. Finally, we briefly discuss the therapeutic targeting of vGPCRs as future treatment of acute and chronic herpesvirus infections.

Indexed as

Epstein-Barr Virus InfectionsHerpesviridaeChemokinesHerpesvirus 4, HumanHumansLigandsReceptors, ChemokineReceptors, VirusChemokinesLigandsReceptors, ChemokineReceptors, VirusU51 protein, human herpesvirus 6broad-spectrum ligand bindingchemokine receptorGPCR structureG protein signalingherpesvirus

Identifiers

PMID35671566
PMCPMC9584139
OpenAlexW4281612800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.